|
Our Advocacy Issues
In addition to our advocacy priorities, the Society for Women’s Health Research is involved with or monitors a number of issues that either directly or indirectly affect the health of all women. The following issues are all of fundamental importance to women’s health.
Clinical Trials*
SWHR's goal for the future of clinical trials is to guarantee the inclusion of women in all phases of clinical trials with sufficient representation to allow for analysis by sex, ethnicity and other demographics. In addition, efforts will be directed to the Food and Drug Administration (FDA) to ensure that appropriate sex-based analysis is performed in clinical trials so that prescription drug labeling will reflect important differences between women and men .
Cloning
SWHR supports actions aimed at securing a ban on human cloning while protecting important biomedical research. SWHR, a member of the Coalition for the Advancement of Medical Research (CAMR), has played an active role in encouraging members of Congress to support therapeutic cloning for biomedical research.
Comparative Effectiveness*
SWHR has long advocated that a strong patient-centered comparative effectiveness research (CER) program can provide value to understanding biological and physiological sex differences affecting disease prevention, diagnosis, and treatment.
Food and Drug Administration (FDA) Funding
SWHR strongly believes that appropriate funding of the FDA by Congress is critical for the Agency to function and to assure the American public of the safety of its food and drugs.
Funding for Research in Women's Health*
SWHR's goal is to ensure adequate funding for the governmental offices that support women's health research in National Institutes of Health, Department of Health and Human Services, Centers for Disease Control and Prevention, Food and Drug Administration, HRSA, Agency for Healthcare Research and Quality and elsewhere.
Genetic Testing
SWHR supports improving research and guidelines for genetic testing for women with inherited breast and ovarian cancer susceptibility in the interest of women’s health.
HIPAA
SWHR supports efforts towards modifying the HIPAA regulations to preserve clinical research to benefit patients, and protecting the privacy of individuals by establishing national requirements for handling medical information while preserving and promoting research.
Human Subject Protection
SWHR supports increasing human subject protections to alleviate women's fear of participating in clinical trials.
Medical Product Liability and Medical Malpractice
SWHR is working to implement changes in the areas of liability and malpractice to ensure that women’s health research is not harmed by these factors.
Medical Technology and Reimbursement
SWHR is working to ensure that Americans have access to these life-saving screening tools and laboratory tests and that government and private health plans offer reimbursement for these technologies as they do for other forms of treatment.
Politicization of Science
SWHR opposes the injection of politics and ideology into scientific research.
Reimportation of Drugs
SWHR emphasizes the importance of securing access to safe drugs for women.
Sex-based Biology*
SWHR's goal is for sex-based biology to be integrated and recognized as an essential element of all research.
Stem Cell Research
SWHR supports new medical research involving stem cells that holds promise for the treatment of human disease and disability.
Tobacco
SWHR supports funding for research on sex differences related to nicotine addiction, smoking cessation and tobacco-related illnesses in addition to supporting public education for women and adolescents on the gender differences in the health effects of smoking.
*Indicates SWHR Advocacy Priority |
